[
  {
    "ts": null,
    "headline": "Equities Slump, Gold Surges Intraday After Trump's Latest Tariff Threat",
    "summary": "US benchmark equity indexes tumbled intraday, while gold and silver prices hit new record highs afte",
    "url": "https://finnhub.io/api/news?id=d13ce274a72b507d3c941417b40ee13959dc735d68da06bb05e057d89703758b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768936733,
      "headline": "Equities Slump, Gold Surges Intraday After Trump's Latest Tariff Threat",
      "id": 138189395,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes tumbled intraday, while gold and silver prices hit new record highs afte",
      "url": "https://finnhub.io/api/news?id=d13ce274a72b507d3c941417b40ee13959dc735d68da06bb05e057d89703758b"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says He Was Wrong for Selling Johnson & Johnson for the Charitable Trust",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks on Jim Cramer’s game plan for this week. Cramer explained why he sold the stock for the Charitable Trust, as he commented: “Wednesday morning brings two stocks that are hard to keep down. Johnson & Johnson and Charles Schwab. J&J has become a pure play on […]",
    "url": "https://finnhub.io/api/news?id=2262323a5c7a1a686a512528fad2691596d5bebc234fe0db61293711bdbd27a4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768924975,
      "headline": "Jim Cramer Says He Was Wrong for Selling Johnson & Johnson for the Charitable Trust",
      "id": 138188461,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the stocks on Jim Cramer’s game plan for this week. Cramer explained why he sold the stock for the Charitable Trust, as he commented: “Wednesday morning brings two stocks that are hard to keep down. Johnson & Johnson and Charles Schwab. J&J has become a pure play on […]",
      "url": "https://finnhub.io/api/news?id=2262323a5c7a1a686a512528fad2691596d5bebc234fe0db61293711bdbd27a4"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on Intuitive Surgical: “One day, These Upside Surprises Will Come to an End”",
    "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? I think that the lone surprise blowout next week will come from Intuitive Surgical, which had a monster quarter last time. But I bet that […]",
    "url": "https://finnhub.io/api/news?id=ad4931e4ff8ad15e9dec3874efe8222758ac99f0d4da2c9ee39b32e199eb66b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768924968,
      "headline": "Jim Cramer on Intuitive Surgical: “One day, These Upside Surprises Will Come to an End”",
      "id": 138188462,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the stocks on Jim Cramer’s game plan for this week. Cramer was bullish on the company’s upcoming quarter, as he said: “What else? I think that the lone surprise blowout next week will come from Intuitive Surgical, which had a monster quarter last time. But I bet that […]",
      "url": "https://finnhub.io/api/news?id=ad4931e4ff8ad15e9dec3874efe8222758ac99f0d4da2c9ee39b32e199eb66b0"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says Charles Schwab Is One of the “Three Biggest Beneficiaries of My Aging Generation”",
    "summary": "The Charles Schwab Corporation (NYSE:SCHW) is one of the stocks on Jim Cramer’s game plan for this week. Cramer highlighted it as one of the stocks that is “hard to keep down,” as he remarked: “Wednesday morning brings two stocks that are hard to keep down. Johnson & Johnson and Charles Schwab… How about Charles […]",
    "url": "https://finnhub.io/api/news?id=69cb175120d9557925203d3dc8436541a0b5667794f84771ba2e99330c245310",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768924965,
      "headline": "Jim Cramer Says Charles Schwab Is One of the “Three Biggest Beneficiaries of My Aging Generation”",
      "id": 138188463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The Charles Schwab Corporation (NYSE:SCHW) is one of the stocks on Jim Cramer’s game plan for this week. Cramer highlighted it as one of the stocks that is “hard to keep down,” as he remarked: “Wednesday morning brings two stocks that are hard to keep down. Johnson & Johnson and Charles Schwab… How about Charles […]",
      "url": "https://finnhub.io/api/news?id=69cb175120d9557925203d3dc8436541a0b5667794f84771ba2e99330c245310"
    }
  },
  {
    "ts": null,
    "headline": "Robotic surgery fuels Johnson & Johnson dividend growth outlook",
    "summary": "Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification. That's a big deal because it marks J&J's formal entry into the fast-growing robotic ...",
    "url": "https://finnhub.io/api/news?id=f147a8bd005145aa567d4571b68338450bac1aeb1034acda45c860cacf5621f0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768923420,
      "headline": "Robotic surgery fuels Johnson & Johnson dividend growth outlook",
      "id": 138187435,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (JNJ) just made a move that investors have been waiting years to see. The healthcare heavyweight submitted its OTTAVA robotic surgical system to the FDA for De Novo classification. That's a big deal because it marks J&J's formal entry into the fast-growing robotic ...",
      "url": "https://finnhub.io/api/news?id=f147a8bd005145aa567d4571b68338450bac1aeb1034acda45c860cacf5621f0"
    }
  },
  {
    "ts": null,
    "headline": "Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case",
    "summary": "BAYRY jumps 6.4% after the Supreme Court agrees to review the Durnell Roundup case, a key test of federal preemption in glyphosate litigation.",
    "url": "https://finnhub.io/api/news?id=b51d69bc289178eb3430289cddc95ff5e875d4244401a29ca91d233444a400dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768916160,
      "headline": "Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup Case",
      "id": 138187436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "BAYRY jumps 6.4% after the Supreme Court agrees to review the Durnell Roundup case, a key test of federal preemption in glyphosate litigation.",
      "url": "https://finnhub.io/api/news?id=b51d69bc289178eb3430289cddc95ff5e875d4244401a29ca91d233444a400dc"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: 3M stock sinks, D.R. Horton rises to kick off busy week of earnings",
    "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
    "url": "https://finnhub.io/api/news?id=c284a9d52b6740e9769f49db87daed2a054a13f0d85c6aec54c1b387b0216fa2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768915564,
      "headline": "Earnings live: 3M stock sinks, D.R. Horton rises to kick off busy week of earnings",
      "id": 138186418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
      "url": "https://finnhub.io/api/news?id=c284a9d52b6740e9769f49db87daed2a054a13f0d85c6aec54c1b387b0216fa2"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Fall as Investors Assess Trump's Tariff Announcement, Await Earnings",
    "summary": "The benchmark US stock measures fell before the opening bell Tuesday amid renewed trade tensions bet",
    "url": "https://finnhub.io/api/news?id=2dd943ff2f5cb942181b39b369b69c61c5b2ee2140031994bf09e2d8ec2bf510",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768912805,
      "headline": "Stocks Fall as Investors Assess Trump's Tariff Announcement, Await Earnings",
      "id": 138186326,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The benchmark US stock measures fell before the opening bell Tuesday amid renewed trade tensions bet",
      "url": "https://finnhub.io/api/news?id=2dd943ff2f5cb942181b39b369b69c61c5b2ee2140031994bf09e2d8ec2bf510"
    }
  },
  {
    "ts": null,
    "headline": "CURE: Benefits And Caveats Of The Leveraged Healthcare ETF",
    "summary": "Direxion CURE ETF offers 3x daily healthcare exposureâlearn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.",
    "url": "https://finnhub.io/api/news?id=ca3612c5b4891b901620bb4fdb6c38f001242d9ac0824dccbf1890b2577a24b9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768912790,
      "headline": "CURE: Benefits And Caveats Of The Leveraged Healthcare ETF",
      "id": 138188296,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1351287260/image_1351287260.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Direxion CURE ETF offers 3x daily healthcare exposureâlearn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.",
      "url": "https://finnhub.io/api/news?id=ca3612c5b4891b901620bb4fdb6c38f001242d9ac0824dccbf1890b2577a24b9"
    }
  },
  {
    "ts": null,
    "headline": "This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up.",
    "summary": "Investors expect a surge in deal activity in 2026 as drug makers look to replenish pipelines and capitalize on low interest rates.",
    "url": "https://finnhub.io/api/news?id=ed09b44ab08f281a4de088cbafeaab49cefc834f8df46627d296be0c707030c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768911000,
      "headline": "This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up.",
      "id": 138186420,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Investors expect a surge in deal activity in 2026 as drug makers look to replenish pipelines and capitalize on low interest rates.",
      "url": "https://finnhub.io/api/news?id=ed09b44ab08f281a4de088cbafeaab49cefc834f8df46627d296be0c707030c5"
    }
  },
  {
    "ts": null,
    "headline": "Option Volatility And Earnings Report For January 20 - 23",
    "summary": "Earnings season ramps up this week with some big names set to report. This week we have Netflix, Intel, Johnson & Johnson, Freeport McMoran and 3M Company all reporting in what shapes as a busy and pivotal week for stocks.",
    "url": "https://finnhub.io/api/news?id=ffb659d4d38b8f1101460eda9742ab00e572fd744dda5e824b0ed27e6ff7f81a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768910402,
      "headline": "Option Volatility And Earnings Report For January 20 - 23",
      "id": 138187437,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Earnings season ramps up this week with some big names set to report. This week we have Netflix, Intel, Johnson & Johnson, Freeport McMoran and 3M Company all reporting in what shapes as a busy and pivotal week for stocks.",
      "url": "https://finnhub.io/api/news?id=ffb659d4d38b8f1101460eda9742ab00e572fd744dda5e824b0ed27e6ff7f81a"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Just Can’t Stop Praising Johnson & Johnson (JNJ)",
    "summary": "We recently published 15 Fresh Stocks Jim Cramer Discussed. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed. Jim Cramer has turned quite optimistic on pharmaceutical firm Johnson & Johnson (NYSE:JNJ) lately. Most of the CNBC TV host’s optimism stems from the firm’s cancer drug portfolio and its decision to spin off […]",
    "url": "https://finnhub.io/api/news?id=007dc112b2182fdace896efa584db781fcad7e91464a005e44642df5280e840c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768906926,
      "headline": "Jim Cramer Just Can’t Stop Praising Johnson & Johnson (JNJ)",
      "id": 138185671,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "We recently published 15 Fresh Stocks Jim Cramer Discussed. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer discussed. Jim Cramer has turned quite optimistic on pharmaceutical firm Johnson & Johnson (NYSE:JNJ) lately. Most of the CNBC TV host’s optimism stems from the firm’s cancer drug portfolio and its decision to spin off […]",
      "url": "https://finnhub.io/api/news?id=007dc112b2182fdace896efa584db781fcad7e91464a005e44642df5280e840c"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Netflix, Johnson & Johnson, Intel, Paramount Skydance and Warner Bros Discovery",
    "summary": "Netflix kicks off a pivotal week as major earnings roll in, with media deal drama and global policy events shaping market sentiment.",
    "url": "https://finnhub.io/api/news?id=9fec96d17bf7f5e46278ff8d28ed01887d01500f0092156dd19b4516f6de4646",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768898220,
      "headline": "The Zacks Analyst Blog Highlights Netflix, Johnson & Johnson, Intel, Paramount Skydance and Warner Bros Discovery",
      "id": 138185672,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Netflix kicks off a pivotal week as major earnings roll in, with media deal drama and global policy events shaping market sentiment.",
      "url": "https://finnhub.io/api/news?id=9fec96d17bf7f5e46278ff8d28ed01887d01500f0092156dd19b4516f6de4646"
    }
  },
  {
    "ts": null,
    "headline": "Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged",
    "summary": "Pledged projects have landed in a handful of hotspots while giving rise to potential new hubs across the U.S.",
    "url": "https://finnhub.io/api/news?id=29eb1b73de3a68aad76b4ce27ece84f3cb32f6b1356d04dcd510e0c438ca2f2b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768895656,
      "headline": "Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged",
      "id": 138186415,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pledged projects have landed in a handful of hotspots while giving rise to potential new hubs across the U.S.",
      "url": "https://finnhub.io/api/news?id=29eb1b73de3a68aad76b4ce27ece84f3cb32f6b1356d04dcd510e0c438ca2f2b"
    }
  },
  {
    "ts": null,
    "headline": "Trump at Davos, Netflix Earnings, Supreme Court: What to Watch This Week",
    "summary": "Earnings season kicks up a gear, with announcements expected from companies including Johnson & Johnson, Intel and Netflix. Plus, President Trump has headed to the annual World Economic Forum in Davos, Switzerland, where he says he has agreed to meet with various parties regarding Greenland.",
    "url": "https://finnhub.io/api/news?id=a02129349346f09f74e1715240106fe8b01b5480f6372dbcc7d39959e02c2c7e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768895478,
      "headline": "Trump at Davos, Netflix Earnings, Supreme Court: What to Watch This Week",
      "id": 138185011,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Earnings season kicks up a gear, with announcements expected from companies including Johnson & Johnson, Intel and Netflix. Plus, President Trump has headed to the annual World Economic Forum in Davos, Switzerland, where he says he has agreed to meet with various parties regarding Greenland.",
      "url": "https://finnhub.io/api/news?id=a02129349346f09f74e1715240106fe8b01b5480f6372dbcc7d39959e02c2c7e"
    }
  },
  {
    "ts": null,
    "headline": "CAPLYTA Shows Stronger Remission Results in Phase 3 MDD Data, JNJ Says",
    "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 13 Best Dividend Kings to Buy in 2026. On January 16, Johnson & Johnson (NYSE:JNJ) shared results from a new analysis of Phase 3 data showing that CAPLYTA (lumateperone), when used alongside an antidepressant, delivered significantly higher remission rates in adults with major depressive disorder compared with […]",
    "url": "https://finnhub.io/api/news?id=73ea9146b41c0bba846bb19db7fa9cdbb6a68a12c3882f81d11fb34d74e2d895",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768872304,
      "headline": "CAPLYTA Shows Stronger Remission Results in Phase 3 MDD Data, JNJ Says",
      "id": 138181935,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is included among the 13 Best Dividend Kings to Buy in 2026. On January 16, Johnson & Johnson (NYSE:JNJ) shared results from a new analysis of Phase 3 data showing that CAPLYTA (lumateperone), when used alongside an antidepressant, delivered significantly higher remission rates in adults with major depressive disorder compared with […]",
      "url": "https://finnhub.io/api/news?id=73ea9146b41c0bba846bb19db7fa9cdbb6a68a12c3882f81d11fb34d74e2d895"
    }
  }
]